FDA Clinical Trials Services


Quintiles Phase 1 Clinical Research Unit


In concert with Quintiles and other CRO's, Doctors Jemshed A. Khan and Robert Rymer have performed Ophthalmology services for FDA Phase 1, 2, and 3 clinical trials for many years. Currently, Dr. Khan and Dr. Robert Rymer, MD collaborate and work closely with Dr. Phillip Leese, MD, Medical Director and Quintiles' physicians at Qunitiles Kansas City Area Phase I Clinical Research Unit in Overland Park, Kansas. Quintiles is the world's leading provider of pharmaceutical research contract services and has helped develop all 30 of the world's leading pharmaceuticals.

We pride ourselves in being thorough, flexible, and efficient clinicians. We work closely with our certified ophthalmic assistants, study subjects, Quintiles physicians and study sponsors in order to quickly address any questions or needs. We are happy to accommodate study-specific sponsor requests for additional specialized testing. For example, in order to fulfill sponser requests we have undertaken certification or additional training in advanced techniques such as LOCS III certification, electroretinography (ERG), and Zeiss Stratus OCT. We will travel nationally to address study-site specific concerns or provide independent evaluation services.


Robert Rymer, MD Jemshed A Khan, MD


We offer the following research Ophthalmologic services:

Specialized training, equipment, or testing for FDA studies:

 Certification for Human Studies:


Partial listing of FDA Studies:

 We have performed Ophthalmological services for the following FDA study sponsors:

Premier Laser: A Phase 1 study to detrmine the Efficacy and Safety of Polaris™ 1.32 Nd:YAG laser system for tissue melding skin closure.